Principal Applied Scientist
MultiPlan | |
United States | |
Mar 30, 2026 | |
|
At Claritev, our mission is to simplify healthcare workflows, improve transparency, and bend the healthcare cost curve. We believe that data, technology, and AI can fundamentally transform how healthcare operates by automating complex workflows, improving decision-making, and reducing unnecessary costs across the system. By combining deep healthcare expertise with advanced analytics and AI, we help payers, providers, and employers operate more efficiently and deliver better outcomes for the people they serve. We are bold in our thinking, rigorous in execution, and committed to service excellence for every stakeholder. Our culture values innovation, accountability, diversity of thought, and collaboration. Join us as we accelerate our transformation into a leading technology and AI-driven company shaping the future of healthcare. JOB SUMMARY: We are seeking a Principal Applied Scientist to lead the research, development, and deployment of advanced machine learning and AI systems that power Claritev's next generation of healthcare products. This is a hands-on technical leadership role for an experienced applied scientist who thrives at the intersection of research innovation, real-world deployment, and measurable business impact. You will architect and deliver predictive, generative, and agentic AI systems that automate complex healthcare workflows and unlock new insights from large-scale healthcare data. In this role, you will work closely with Product, Engineering, and business leaders to translate cutting-edge research into scalable production solutions that improve transparency, reduce costs, and simplify healthcare operations. You will also serve as a technical thought leader and mentor, helping shape Claritev's AI strategy and elevating the scientific rigor and innovation of the organization. KEY RESPONSIBILITIES:
Innovation & Applied Research
Product & Business Impact
Engineering & Production Excellence
Collaboration & Mentorship
Governance & Compliance
| |
Mar 30, 2026